ClinicalTrials.gg
Sign In

Drug

MK-0524 clinical trials

Also written MK0524.

studies test it
24
open now
0
in phase 3
7
first study started
2003

How studies write it

Studies that test it under each name

Name

Comparator: laropiprant
3

Development codes

MK0524
2

Other names

Laropiprant
1

Combined with it in one product

Tredaptive
10
niacin (+) laropiprant
6
MK0524A
6
Niacin/Laropiprant
3
nicotinic acid/laropiprant
1
Comparator: niacin + laropiprant
1
tredaptive (nicotinic acid/ laropiprant)
1
Comparator: MK0524 + montelukast
1

Studies by the year they started

24 studies that test it; most in 2007 (5)

Studies that test MK-0524, by start year
YearStudies
20031
20041
20052
20061
20075
20081
20093
20104
20115
20121

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
3
Phase 3
7
Phase 4
9
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Hypercholesterolemia
6
Dyslipidemias
3
Diabetes Mellitus, Type 2
2
Polycystic Ovary Syndrome
1
Rhinitis, Allergic, Seasonal
1
Asthma
1
Rosacea
1
Cardiovascular Diseases
1
Coronary Disease
1
Atherosclerosis
1
Coronary Artery Disease
1
Metabolic Syndrome
1

Who runs them

Industry 13 · Other 11

Merck Sharp & Dohme LLC (13) · Manchester University NHS Foundation Trust (1) · Hull University Teaching Hospitals NHS Trust (1) · Institut Investigacio Sanitaria Pere Virgili (1) · University of Oxford (1) · Instituto Aragones de Ciencias de la Salud (1) · University Medical Centre Ljubljana (1) · Calmy Alexandra (1)

Often tested with

Tested in the same studies.

Niacin (20) · Fenofibrate (2) · Aspirin (1) · Clopidogrel (1) · Montelukast (1) · Simvastatin (1) · Atorvastatin (1) · Rosuvastatin (1)

Studies

Open first, then newest update. How each study uses MK-0524 is read from its arms, and is right about nine times in ten.

Testing it · 24

See all 24 studies that test MK-0524 →